Eva Andres-Mateos is the Associate Vice President of Preclinical Development in Gene Therapy at Eli Lilly and Company. A results-oriented leader, she specializes in pharmacology, bioanalytical development, and advancing regulatory strategies from discovery to the early clinical stage. She earned her Ph. D. from Universidad Autónoma de Madrid.
Eva is a passionate advocate for improving the diagnosis and treatment of rare diseases. She actively supports women in science and has highlighted their work in finding treatments for challenging disorders. She maintains strong ties to the Spanish scientific community through organizations like ECUSA (Españoles Científicos en USA).
During her postdoctoral work at Johns Hopkins, she won the prestigious Helen B. Taussig Research Award for her novel research on muscle atrophy using hibernating squirrels.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.